Personalized Therapeutic Strategies in the Management of Osteoporosis in Patients with Autoantibody-Positive Rheumatoid Arthritis

Bone mineral density (BMD) reduction and fragility fractures still represent a major source of morbidity in rheumatoid arthritis (RA) patients, despite adequate control of the disease. An increasing number of clinical and experimental evidence supports the role of autoantibodies, especially anti-cit...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Onofrio, Bernardo, di Lernia, Michele, De Stefano, Ludovico, Bugatti, Serena, Montecucco, Carlomaurizio, Bogliolo, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104810/
https://www.ncbi.nlm.nih.gov/pubmed/35566466
http://dx.doi.org/10.3390/jcm11092341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104810/
https://www.ncbi.nlm.nih.gov/pubmed/35566466
http://dx.doi.org/10.3390/jcm11092341

Ejemplares similares